Identification and evaluation of tumor pyroptosis-associated antigens for design a vaccine candidate against lung cancer
Scientific Reports · 19.03.2026 · 16 (1)
DOI: 10.1038/s41598-024-84792-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, online erschienen am 19.03.2026. Verfasst von Truc Ly Nguyen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Republic o…. Hauptthemen laut MEDLINE: Lung Neoplasms, Cancer Vaccines, Pyroptosis, Antigens, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research of Animal and Plant Quarantine Agency, Republic of Korea.
Abstract (Originalsprache)
Lung cancer is the leading cause of cancer-related mortality worldwide, emphasizing the need for innovative therapeutic strategies. This study utilized immunoinformatics and structural bioinformatics approaches to design and evaluate a multi-epitope vaccine targeting pyroptosis-associated antigens (CARD8, NAIP, NLRP1, and NLRP3), which are implicated in lung cancer immunology. Fifteen T-cell and B-cell epitopes were identified, analyzed for their antigenicity, non-toxicity, non-allergenicity, and immune-stimulatory potential, and optimized to construct a vaccine with suitable adjuvants and linkers. The vaccine demonstrated high antigenicity, solubility, and stability, as validated through physicochemical analyses. Its three-dimensional structure was modeled, refined, and validated using molecular modeling approaches. Molecular docking studies revealed stable and strong interactions between the vaccine and key immune receptors (TLR2, TLR4, TLR5, TLR3, TLR7, and TLR8), indicating its potential to activate both innate and adaptive immunity. Molecular dynamics simulations confirmed the vaccine’s structural stability and solvent accessibility over 100 ns across ten replicas. Immune simulations demonstrated strong immunogenic responses, including elevated antibody titers, memory cell populations, and cytokine production. Codon optimization and in silico cloning further ensured efficient expression in Escherichia coli , facilitating experimental application. These findings underscore the vaccine’s promise as a therapeutic candidate against lung cancer, warranting further in vitro and in vivo investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
- Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Republic of Korea. heebal@snu.ac.kr.
- Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, 08826, Republic of Korea. heebal@snu.ac.kr.
- eGnome, Inc., Seoul, 05836, Republic of Korea. heebal@snu.ac.kr.
Förderung
- Research of Animal and Plant Quarantine Agency, Republic of Korea
Zitieren
APA
Nguyen, T. L., & Kim, H. (2026). Identification and evaluation of tumor pyroptosis-associated antigens for design a vaccine candidate against lung cancer. Scientific Reports, 16(1). https://doi.org/10.1038/s41598-024-84792-4
Vancouver
Nguyen TL, Kim H. Identification and evaluation of tumor pyroptosis-associated antigens for design a vaccine candidate against lung cancer. Scientific Reports. 2026;16(1). doi:10.1038/s41598-024-84792-4
BibTeX
@article{Nguyen2026,
author = {Nguyen, Truc Ly and Kim, Heebal},
title = {Identification and evaluation of tumor pyroptosis-associated antigens for design a vaccine candidate against lung cancer},
journal = {Scientific Reports},
year = {2026},
volume = {16},
number = {1},
doi = {10.1038/s41598-024-84792-4}
}
EUVIMED